What is Foundayo?
Foundayo contains orforglipron, a daily prescription GLP-1 tablet. The MHRA authorised it on 10 August 2026 for adult weight management and type 2 diabetes under specified criteria. It is a different medicine from semaglutide and tirzepatide.
UK approval is not a stock guarantee
Authorisation sets the permitted use of a medicine; it does not confirm every pharmacy can supply it. The MHRA announcement said Foundayo was not available on the NHS at that time. Check current local access rather than assuming private availability means NHS funding.
Before relying on a price, establish whether it is a published dispensing offer, an indicative figure or a waitlist. Ask what happens to any payment if stock is delayed or the clinical assessment concludes that treatment is unsuitable.
How to compare Foundayo costs
Use Dayo’s dedicated Foundayo table to check current listings. Match the strength, tablet quantity and treatment period. Ask the provider to separate the medicine price from consultation, delivery and ongoing review charges.
Med Easy connects to Dayo’s public summary feed and shows its source-listed figures alongside the original check date; an older check is clearly labelled. The external table and the provider’s final quote are the relevant sources for an actual order.
Questions for the prescribing service
- Is the listed medicine available now, and in the prescribed strength?
- How many days does the quoted supply cover?
- What is included in follow-up, and who answers clinical questions?
- How are repeat prescriptions arranged?
- What are the cancellation, refund and delivery terms?
Discuss other medicines and any change of treatment with your prescriber. A tablet format does not remove the need for an individual assessment.
Foundayo NHS funding: check the decision, not a forecast
The August 2026 authorisation did not establish NHS availability. NICE’s appraisal page is the place to check its current status. An appraisal in development or an expected publication date is not a funding decision or a promised start date.
Dayo is our Foundayo price reference
Med Easy connects to Dayo’s Foundayo comparison. Its checking method describes dose-specific provider prices, compulsory costs, purchase conditions and rolling checks. A pharmacy checkout remains the final source for the payable amount.
The verification date controls what Med Easy displays. A feed downloaded today can still contain an older price check. If the source verification exceeds our freshness window, the numerical summary is withheld and the direct comparison link remains available.
NHS support without a product promise
Discuss the appropriate weight-management pathway with your GP. Oviva and other commissioned services are assessment and support routes where locally available; listing them does not mean they prescribe Foundayo on the NHS. Treatment decisions follow clinical assessment and applicable funding.
Your questions, answered
Is Foundayo approved in the UK?
Yes. The MHRA authorised orforglipron, branded Foundayo, on 10 August 2026. Clinical eligibility, funding and supply still need to be checked.
Is Foundayo the same as the Wegovy pill?
No. Foundayo contains orforglipron. The Wegovy pill contains semaglutide. A clinician should assess which treatment, if any, is appropriate.
Can an NHS provider guarantee this medicine?
No. A referral is for assessment under the relevant local pathway. The clinical decision and funding arrangements determine what treatment, if any, is offered.
Sources & further reading
Source material checked 20 October 2026. Follow the original publication to check current arrangements. The source labels describe the publisher; they are not a quality rating.
- MHRA: UK authorisation of orforglipron (Foundayo) ↗NHS or public authoritygov.uk
- Monj: how the comparison service works ↗Comparison sourcemonj.co.uk
- NICE: orforglipron appraisal status ↗NHS or public authoritynice.org.uk
- Dayo: how Foundayo prices are checked ↗Comparison sourcedayo.co.uk
- Oviva: NHS referral routes by ICB ↗Provider or specialist organisationoviva.com